|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,420 SEK | -2.42% |
|
0.00% | -6.92% |
Elicera Therapeutics AB (publ) has entered into agreements with Mangold regarding the position as Certified Adviser and Liquidity provider. Mangold will take over as Certified adviser and Liquidity provider on May 15, 2024. Until then, Carnegie will continue to act as Certified Adviser and Liquidity providers to the Company.
Elicera is consequently increasing the cooperation with Mangold, that recently has acted as financial advisor for the recently completed new issue.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.92% | 104M | |
| +2.13% | 44.85B | |
| +12.52% | 12.28B | |
| +21.44% | 7.43B | |
| -5.35% | 7B | |
| -5.28% | 5.8B | |
| +1.89% | 3.44B | |
| +3.51% | 1.68B | |
| 0.00% | 1.22B | |
| -17.07% | 1.13B |
MANGOLD FONDKOMMISSION AB 
